Science & Enterprise, By Alan, on May 3rd, 2016.
3 May 2016. A technology that blocks RNA molecules from activating chemicals in the body suppressing the working of genes to treat or prevent disease received a U.S. patent. The technology was licensed to RaNA Therapeutics in Cambridge, Massachusetts, co-founded by lead inventor Jeannie Lee, a professor of genetics and pathology at Mass. General and Harvard Medical School.
The first therapies under development are treatments for the rare central nervous system disorders spinal muscular atrophy and Friedreich’s ataxia, both programs are still in preclinical stages.
Thursday, May 5, 2016
Subscribe to:
Posts (Atom)